Experts have developed a first-of-its-kind fluorinated contrast agent they believe will provide more detailed MR imaging and aid in the treatment of certain cancers. 

Elutia, formerly known as Aziyo Biologics, is already targeting additional uses for the newly approved device. 

Buzzworthy developments of the past few days.

AI won’t fulfill its promise to transform American medicine if it isn’t appropriately integrated, step by step, across U.S. healthcare.

The U.S. Court of Appeals of the Fourth Circuit temporarily blocked the buyout of two North Carolina hospitals after an FTC appeal.

In some cases, MRI with sedation can delay workflows by 60 minutes or more, putting staff and patients in a bind.

The last day for providers and suppliers to apply for Medicare reimbursement through the advanced payment program is July 12.

Delaying TAVR in eligible patients with severe AS can lead to much higher healthcare costs, according to a new study of real-world Medicare data.

Ascension Health in Texas uses AI that can read CT scans for stroke and pulmonary embolism to activate care teams before the images even get into the PACS.

As a person’s concentration dwindles during resting state or task-based sequences, the resultant brain activity observed on imaging could be misleading.